SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001477932-21-006892
Filing Date
2021-09-29
Accepted
2021-09-29 16:46:23
Documents
6
Period of Report
2021-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K betrf_6k.htm 6-K 9650
2 MATERIAL CHANGE REPORT betrf_ex991.htm EX-99.1 57579
3 betrf_ex991img1.jpg GRAPHIC 4258
4 betrf_ex991img2.jpg GRAPHIC 4005
5 betrf_ex991img3.jpg GRAPHIC 6639
6 betrf_ex991img4.jpg GRAPHIC 3940
  Complete submission text file 0001477932-21-006892.txt   94889
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 438-884-8841
BetterLife Pharma Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 333-161157 | Film No.: 211292299
SIC: 2834 Pharmaceutical Preparations